Annual Working Capital
$122.22 M
+$81.38 M+199.26%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual working capital is $122.22 million, with the most recent change of +$81.38 million (+199.26%) on December 31, 2023.
- During the last 3 years, CTNM annual working capital has risen by +$56.12 million (+84.89%).
- CTNM annual working capital is now at all-time high.
Performance
CTNM Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$209.34 M
-$7.24 M-3.34%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly working capital is $209.34 million, with the most recent change of -$7.24 million (-3.34%) on September 30, 2024.
- Over the past year, CTNM quarterly working capital has increased by +$87.11 million (+71.28%).
- CTNM quarterly working capital is now -3.34% below its all-time high of $216.58 million, reached on June 30, 2024.
Performance
CTNM Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CTNM Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +199.3% | +71.3% |
| 3 y3 years | +84.9% | +412.6% |
| 5 y5 years | +84.9% | +412.6% |
CTNM Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +199.3% | -3.3% | +412.6% |
| 5 y | 5-year | at high | +199.3% | -3.3% | +412.6% |
| alltime | all time | at high | +199.3% | -3.3% | +412.6% |
Contineum Therapeutics Class A Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $209.34 M(-3.3%) |
| Jun 2024 | - | $216.58 M(+90.9%) |
| Mar 2024 | - | $113.48 M(-7.2%) |
| Dec 2023 | $122.22 M | $122.22 M(-6.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $130.09 M(+218.5%) |
| Dec 2022 | $40.84 M(-38.2%) | - |
| Dec 2022 | - | $40.84 M |
| Dec 2021 | $66.11 M | - |
FAQ
- What is Contineum Therapeutics Class A annual working capital?
- What is the all time high annual working capital for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual working capital year-on-year change?
- What is Contineum Therapeutics Class A quarterly working capital?
- What is the all time high quarterly working capital for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly working capital year-on-year change?
What is Contineum Therapeutics Class A annual working capital?
The current annual working capital of CTNM is $122.22 M
What is the all time high annual working capital for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual working capital is $122.22 M
What is Contineum Therapeutics Class A annual working capital year-on-year change?
Over the past year, CTNM annual working capital has changed by +$81.38 M (+199.26%)
What is Contineum Therapeutics Class A quarterly working capital?
The current quarterly working capital of CTNM is $209.34 M
What is the all time high quarterly working capital for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly working capital is $216.58 M
What is Contineum Therapeutics Class A quarterly working capital year-on-year change?
Over the past year, CTNM quarterly working capital has changed by +$87.11 M (+71.28%)